Buy CBD Oil – Your Ultimate Guide

Can we legally buy and take in cannabis in France today? Yes and no. Yes, because the state has relaxed its guidelines on CBD, including through the Minister of Health. And no, at the same time, because only products consisting of cannabidiol (CBD), an active substance that does not have the psychedelic impacts credited to THC, are thought about legal. Let us analyze what is legal and what is not with regard to cannabis and CBD.

CBD is legal in France, but THC is not

Marijuana should not be confused with cannabidiol. Specifically given that the 2nd is legal in certain forms in France … While the other is not! Since cannabidiol (understood by the acronym CBD) is simply one of the many active compounds from the hemp plant, which does not have the psychedelic impacts of its cousin THC – the one that makes you “stone”.

Simply put, what is normally called “cannabis”, which includes high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And therefore prohibited in France as in numerous countries on the planet. On the other hand, cannabis which offers pride of place to the cannabinoid known as cannabidiol, it is legal as long as its THC levels do not go beyond 0.2%.

Nevertheless, the legislation stays vague in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in a smokeless cigarette. But it is also discovered in other forms (including oil or paste), without its purchase and consumption being reprehensible … To try to make it basic, let’s state that CBD is not restricted by French law, unlike THC


Although CBD and THC are identical, they are very different. These are the very best understood of the 500 cannabinoids discovered in hemp. And each has its particular impacts. THC is especially understood for its psychedelic properties: it triggers a modification in the state of awareness by acting directly on the brain. By taking in cannabis rich in THC, we “hover”: well-being, ecstasy, relaxation … But also red eyes, dilated pupils and, often, anxiety and even fear.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol remains in the procedure of making its way by virtue of its helpful restorative impacts. CBD helps ease pain and inflammation, minimize anxiety, ease the suffering of victims of anxiety attacks and depression, and even treat certain illness (such as epilepsy or Alzheimer’s). In addition, it has a very low toxicity and presents (practically) no addictive threat, even if the absence of scientific studies decreases these qualities to simple hypotheses.

Legalization of CBD in France: should we go further?

Certainly, the legal development concerning CBD is positive, but whatever stays to be done. The health ministry wishes to be cautious, and the government’s position on the matter resembles a balancing act. At the same time, the National Medicines Agency has clearly spoken up. We therefore take care of the goat and the cabbage so as not to get too included, while the vaporized cannabidiol has been offered in France for a couple of years already, making the most of the legal vagueness that continues.

Beyond the 0.2% THC threshold licensed in marketed products, it should be remembered that only the liquid type of CBD flavor (planned for e cigarettes) is actually legal. The purchase and consumption of resin or smoking cigarettes herb is therefore not regulated, particularly given that the THC level is frequently higher (around 15%). In addition, only making use of seeds and fibers is licensed in France. But what about CBD oil, which allows you to take pleasure in the benefits of the substance without exposing your lungs to potentially hazardous smoke? What about Midnight CBD paste? On these topics, there is radio silence.

In addition, CBD is thought about a “dietary supplement”, which prohibits presenting it as a medicine. And make it an informed ad for users and patients. Regrettable, because, in the meantime, numerous possible recipients are not making the most of it. It is therefore needed to go further and clarify things: more than a question of customer welfare, it refers public health.

Scroll to top